Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Description

The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters, the calculations will be integrated into software in the final commercial product; (ii) obtain human measurements against which both computational models and animal data can be compared.

Conditions

Fetal Hypoxia

Study Overview

Study Details

Study overview

The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters, the calculations will be integrated into software in the final commercial product; (ii) obtain human measurements against which both computational models and animal data can be compared.

Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Condition
Fetal Hypoxia
Intervention / Treatment

-

Contacts and Locations

Walnut Creek

Yaron Friedman, MD, Inc., Walnut Creek, California, United States, 94598

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Women with singleton, healthy pregnancy at gestational age ≥ 36 weeks
  • 2. Age \> 18 years
  • 3. Willing to come in for testing outside of routine business hours (including Saturdays)
  • 1. Age \<18
  • 2. Multiple gestation (twins, triplets)
  • 3. Presentation other than vertex or breech
  • 4. \< 36 weeks of gestation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Raydiant Oximetry, Inc.,

Mark Rosen, MD, STUDY_DIRECTOR, Raydiant Oximetry

Study Record Dates

2025-04-30